OBRI-IBD Inflammatory Bowel Disease Biobank, Canada

Registration Status: Pending

Objective: We are seeking to collect biospecimen linked to clinical data and patient reported outcomes for Canadians with IBD who are using or are highly likely to use biologic and other highly active therapies

Registered Biobank Name OBRI-IBD Inflammatory Bowel Disease Biobank
Biobank Leader Laura.Targownik@sinaihealth.ca
Country Canada
Email for biobank inquiries Laura.Targownik@sinaihealth.ca
Principal Investigator Laura Targownik
User Type
  • Mono: A biobank that supports a specific research project, may have few staff members, a small-scale accrual scope with little to no initial intention of releasing or distributing biospecimens to secondary parties
  • Oligo: A biobank that supports several research groups or clinical trials, may or may not be designed to release biospecimens outside their collaborative group
  • Poly: A biobank that has generally a larger accrual scope, resources, and multiple users outside the biobank proper
Biospecimen Collected: